NCT03050268
- Conditions
- AML, Abnormalities, Multiple, Acute Leukemia, +206 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Clinical trial condition
Neurofibromatosis Type II
Explore clinical trials studying Neurofibromatosis Type II. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Neurofibromatosis Type II trial results
Not Yet Recruiting
Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
NCT07131722
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
- Locations
-
Not specified
Completed
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
NCT01419639
- Conditions
- Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +35 more
- Locations
-
- New York University Medical Center New York, United States